Kaji, K.; Takeda, S.; Iwai, S.; Nishimura, N.; Sato, S.; Namisaki, T.; Akahane, T.; Yoshiji, H.
Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Antioxidants 2024, 13, 1415.
https://doi.org/10.3390/antiox13111415
AMA Style
Kaji K, Takeda S, Iwai S, Nishimura N, Sato S, Namisaki T, Akahane T, Yoshiji H.
Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Antioxidants. 2024; 13(11):1415.
https://doi.org/10.3390/antiox13111415
Chicago/Turabian Style
Kaji, Kosuke, Soichi Takeda, Satoshi Iwai, Norihisa Nishimura, Shinya Sato, Tadashi Namisaki, Takemi Akahane, and Hitoshi Yoshiji.
2024. "Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis" Antioxidants 13, no. 11: 1415.
https://doi.org/10.3390/antiox13111415
APA Style
Kaji, K., Takeda, S., Iwai, S., Nishimura, N., Sato, S., Namisaki, T., Akahane, T., & Yoshiji, H.
(2024). Imeglimin Halts Liver Damage by Improving Mitochondrial Dysfunction in a Nondiabetic Male Mouse Model of Metabolic Dysfunction-Associated Steatohepatitis. Antioxidants, 13(11), 1415.
https://doi.org/10.3390/antiox13111415
